Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Charles & Colvard ( (CTHR) ).
On March 2, 2026, Charles & Colvard, Ltd. filed a voluntary petition for relief under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of North Carolina, seeking to operate as a debtor in possession while it undertakes a comprehensive restructuring. The company has submitted first-day motions to keep paying employees, key vendors, and essential obligations so it can continue normal operations and minimize disruption for workers, suppliers, customers, and other stakeholders.
In a March 3, 2026 announcement, the lab-grown jewelry maker said it aims to use the court-supervised process to implement broad financial and operational changes it believes are needed for long-term viability. Management warned that trading in its common stock during the Chapter 11 case is highly speculative and that shareholders may face significant or total losses, underscoring the elevated risk for equity investors as the restructuring proceeds.
The most recent analyst rating on (CTHR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Charles & Colvard stock, see the CTHR Stock Forecast page.
Spark’s Take on CTHR Stock
According to Spark, TipRanks’ AI Analyst, CTHR is a Neutral.
Charles & Colvard’s stock score is significantly impacted by its poor financial performance and valuation. The company’s strategic move to secure a convertible note agreement provides some positive outlook. However, technical indicators suggest a bearish trend, and the lack of earnings call data prevents a more comprehensive analysis.
To see Spark’s full report on CTHR stock, click here.
More about Charles & Colvard
Charles & Colvard, Ltd., based in North Carolina’s Research Triangle Park and trading over the counter under the ticker CTHR, is a leading producer of lab-grown gemstone jewelry. Founded in 1995, the company is the original creator of lab-grown moissanite and markets its Forever One moissanite and Caydia lab-grown diamond brands, focusing on ethical, above-ground gemstones and recycled precious metals for bridal, high-fashion, and everyday jewelry.
The company positions itself as an ethical fine-jewelry provider, emphasizing its Made, not Mined approach and use of 100% recycled precious metals. It targets consumers seeking sustainable and value-driven alternatives to mined gemstones, selling primarily through its charlesandcolvard.com platform and maintaining a distinctive brand in the lab-grown fine jewelry segment.
Average Trading Volume: 5,235
Technical Sentiment Signal: Sell
Current Market Cap: $228K
For an in-depth examination of CTHR stock, go to TipRanks’ Overview page.